44 results
8-K
EX-10.3
rujlnqc9raqvqc
19 Nov 07
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
y5ets2aapzjz xq4vsu1
5 Jan 15
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.2
r8ozr49im11xas
24 Apr 20
Caladrius Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:02pm
8-K
EX-10.2
flzm35iv80qi1zuy3
15 Sep 22
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
9:16am
8-K
EX-10.2
le2ucn 9g
26 May 20
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
8:02am